Skip to main content

Advertisement

Log in

Analysis of Antitumor Activity of the Liposomal Photosensitizer Lipophthalocyan

  • ONCOLOGY
  • Published:
Bulletin of Experimental Biology and Medicine Aims and scope

We studied specific antitumor activity of a liposomal drug based on tetra-3-phenylthiophthalocyanine aluminum hydroxide (lipophthalocyan) intended for photodynamic therapy. The optimal dose and protocol for photodynamic therapy with lipophthalocyan were chosen in experiments on mice: single intravenous dose of 6 mg/kg with a 5-h interval between administration and laser exposure and irradiation energy density of 400 J/cm2. A wide spectrum antitumor activity of lipophthalocyan was demonstrated in vivo for various transplantable mouse tumors (Lewis lung epidermoid carcinoma, S37 sarcoma, and colon adenocarcinoma AKATOL). The results show the possibility of using lipophthalocyan for photodynamic therapy of tumors of surface localization (skin and mucosa tumors).

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Bol’shakov OP, Neznanov NG, Babakhanyan RV. Didactic and ethical aspects of studies on biomodels and laboratory animals. Kachestv. Klin. Prakt. 2002;(1):24-28. Russian.

    Google Scholar 

  2. Bud’ko AP, Deichman ZG, Meerovich GA, Borisova LM, Meerovich IG, Lanstova AV, Kul’bachevskaya NYu. Study of pharmacokinetics of liposomal photosensitiser based on hydroxyaluminum tetra-3-phenylthiophthalocyanine on mice. Biomedical Photonics. 2018;7(4):16-22. Russian.

    Article  Google Scholar 

  3. Meerovich GA, Borisova LM, Bud’ko AP, Kiseleva MP, Nikolaeva LL, Meerovich IG, Lantsova AV, Chernova SV, Oborotova NA. Study of level and selectivity of liposomal form of photosensitiser hydroxyaluminum tetra-3-phenylthiophthalocyanine accumulation on transplantable mice tumor models at different ways of transplantation. Ross. Bioter. Zh. 2017;16(4):74-79. Russian.

    Google Scholar 

  4. Manual for Preclinical Studies of New Pharmacological Substances. Part I, Mironov AN, ed. Moscow, 2012. P. 642-671. Russian.

  5. Allen CM, Sharman WM, Van Lier JE. Current status of phthalocyanines in the photodynamic therapy of cancer. J. Porphyrins Phthalocyan. 2001;5(2):161-169.

    Article  CAS  Google Scholar 

  6. Allison RR. Future FDT. Photodiagnosis Photodyn. Ther. 2009;6(3-4):231-234.

  7. Allison RR, Sibata CH. Oncologic photodynamic therapy photosensitizers: A clinical review. Photodiagnosis Photodyn. Ther. 2010;7(2):61-75.

    Article  CAS  Google Scholar 

  8. Hopper C. Photodynamic therapy: a clinical reality in the treatment of cancer. Lancet Oncol. 2000;1:212-219.

    Article  CAS  Google Scholar 

  9. Miller JD, Baron ED, Scull H, Hsia A, Berlin JC, McCormick T, Colussi V, Kenney ME, Cooper KD, Oleinick NL. Photodynamic therapy with the phthalocyanine photosensitizer Pc 4: the case experience with preclinical mechanistic and early clinical-translational studies. Toxicol. Appl. Pharmacol. 2007;224(3):290-299.

    Article  CAS  Google Scholar 

  10. Ortel B, Shea CR, Calzavara-Pinton P. Molecular mechanisms of photodynamic therapy. Front. Biosci. (Landmark Ed). 2009;14. P.4157-4172.

    Article  CAS  Google Scholar 

  11. Peng Q, Farrants GW, Madslien K, Bommer JC, Moan J, Danielsen HE, Nesland JM. Subcellular localization, redistribution and photobleaching of sulfonatedaluminumphthalocyanines in a human melanoma cell line. Int. J. Cancer. 1991;49(2):290-295.

    Article  CAS  Google Scholar 

  12. Sanarova EV, Lantsova AV, Polozkova AP, Orlova OL, Meerovich IG, Borisova LM, Kiseleva MP, Smirnova ZS, Kul’bachevskaya NY, Konyaeva OI, Oborotova NA. Effectiveness of liposomal system of delivery of hydrophobic antineoplastic Thiosens photosensitizer. Nanotechnologies in Russia. 2015;10(5-6):492-500.

    Article  CAS  Google Scholar 

  13. Sanarova E, Meerovich I, Lantsova A, Kotova E, Shprakh Z, Polozkova A, Orlova O, Borisova L, Smirnova Z, Oborotova N, Baryshnikov A, Meerovich G, Lukyanets E. Thiosens liposomal dosage form technology development and photodynamic efficiency assessment. J. Drug Deliv. Sci. Technol. 2014;24(4):315-319.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to N. D. Bunyatyan.

Additional information

Translated from Byulleten’ Eksperimental’noi Biologii i Meditsiny, Vol. 168, No. 9, pp. 332-337, September, 2019

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Lantsova, A.V., Borisova, L.M., Meerovich, G.A. et al. Analysis of Antitumor Activity of the Liposomal Photosensitizer Lipophthalocyan. Bull Exp Biol Med 168, 361–365 (2020). https://doi.org/10.1007/s10517-020-04709-9

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10517-020-04709-9

Key Words

Navigation